First Lotus Aortic Valve Implanted in U.K.
March 5, 2014 — Boston Scientific’s Lotus transcatheter aortic valve repair (TAVR) system was implanted for the first time in the United Kingdom at Glenfield Hospital in Leicestershire, U.K. The 23 mm transcatheter gives surgeons control of the valve throughout the keyhole procedure, enabling increased precision and the ability to reposition or retrieve the valve, even after insertion if necessary.
Multiple specialities, including the cardiology team, cardiac surgeons, radiology, nurses and anaesthetic support, worked together to successfully carry out the procedure.
The Lotus valve system employs an Adaptive Seal feature, designed to minimize the paravalvular leakage (PVL).
The system received CE marking in October 2013.
For more information: www.bostonscientific.com
More like this
- First Patient Enrolled in REPRISE II TAVR Trial to Evaluate Lotus Valve
- St. Jude Medical Announces First Transapical Implant of Portico Transcatheter Aortic Heart Valve
- Direct Flow Medical Receives IDE Approval for U.S. Trial of Transcatheter Aortic Heart Valve
- Boston Scientific Announces First Commercial Implants of Lotus Valve System in Europe
- Cardiac Technology Trend Predictions for 2012